Cancer immunology and immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
| Vydáno v: | Springer eBooK. |
|---|---|
| Korporativní autor: | |
| Další autoři: | |
| Médium: | Electronic Resource |
| Jazyk: | English |
| Vydáno: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2011
|
| Edice: | Issues in children's and families' lives
no.2 |
| Témata: | |
| On-line přístup: | Available for University of the Philippines Diliman via SpringerLink. Click here to access |